A major employer in northeast Wisconsin is cutting 12 to 13 percent of its global workforce. Kimberly-Clark is cutting 5,000 to 5,500 jobs, or 12 percent to 13 percent of…

UPM celebrated the official start of the construction of the state-of-the-art biochemicals facility in Leuna, Germany. The biorefinery investment of EUR 550 million is a major milestone in UPM’s strategic transformation. In Leuna, UPM will produce a range of 100% wood-based biochemicals that enable a switch from fossil-based products to sustainable alternatives in a number of end-uses such as plastics, textiles, cosmetics and industrial applications. Technology and process have been developed by UPM over the past ten years, mainly building on the company’s own innovation capabilities and selectively working with international partners. The biorefinery is expected to start up by the end of 2022.The investment has been awarded The Bio Act of the Year 2020 by the World BioEconomy Forum earlier in September this year.

Mercer International Inc. announces that it has received the decision of the tribunal in respect of its previously announced claim against the Government of Canada under the North American Free Trade Agreement. In a split decision, a majority of the tribunal ruled that it lacked jurisdiction to decide certain of the Company's claims under NAFTA and, with respect to the Company's other NAFTA claims, that they were highly complex and technical and that it would be inappropriate for the tribunal to re-determine matters calling for specialist judgment and, as a result, there was no violation of NAFTA. As is customary in these matters, the tribunal awarded costs to Canada of approximately $6.9 million. Click Read More below for additional information.